This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nir-Paz, R.
Right arrow Articles by Wróblewski, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nir-Paz, R.
Right arrow Articles by Wróblewski, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2002, p. 1218-1225, Vol. 46, No. 5
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.5.1218-1225.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to Membrane-Active Peptides and Enrofloxacin in Human Tissue Cell Cultures

Ran Nir-Paz,1,{dagger} Marie-Christine Prévost,1 Pierre Nicolas,2 Alain Blanchard,3 and Henri Wróblewski4*

Unité d'Oncologie Virale, Institut Pasteur,1 Laboratoire de Bioactivation des Peptides, UMR CNRS 7592, Institut Jacques Monod, Université de Paris 7, Paris,2 and Institut de Biologie Moléculaire Végétale, INRA, Villenave d'Ornon,3 UMR CNRS 6026, Université de Rennes I, Campus de Beaulieu, Rennes, France4

Received 2 October 2001/ Returned for modification 6 November 2001/ Accepted 21 December 2001

Mycoplasmas, which are bacteria that are devoid of a cell wall and which belong to the class Mollicutes, are pathogenic for humans and animals and are frequent contaminants of tissue cell cultures. Although contamination of cultures with mycoplasma can easily be monitored with fluorescent dyes that stain DNA and/or with molecular probes, protection and decontamination of cultures remain serious challenges. In the present work, we investigated the susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to the membrane-active peptides alamethicin, dermaseptin B2, gramicidin S, and surfactin by growth inhibition and lethality assays. In the absence of serum, the four peptides killed mycoplasmas at minimal bactericidal concentrations that ranged from 12.5 to 100 µM, but in all cases the activities were decreased by the presence of serum. As a result, under standard culture conditions (10% serum) only alamethicin and gramicidin S were able to inhibit mycoplasma growth (MICs, 50 µM), while dermaseptin B2 and surfactin were ineffective. Furthermore, 8 days of treatment of HeLa cell cultures experimentally contaminated with either mycoplasma species with 70 µM enrofloxacin cured the cultures of infection, whereas treatment with alamethicin and gramicidin S alone was not reliable because the concentrations and treatment times required were toxic to the cells. However, combination of alamethicin or gramicidin S with 70 µM enrofloxacin allowed mycoplasma eradication after 30 min or 24 h of treatment, depending on the mycoplasma and peptide considered. HeLa cell cultures experimentally infected with mycoplasmas should prove to be a useful model for study of the antimycoplasma activities of antibiotics and membrane-active peptides under conditions close to those found in vivo.

* Corresponding author. Mailing address: Université de Rennes I, UMR CNRS 6026, Campus de Beaulieu, F-35042 Rennes Cedex, France. Phone: 33 2 23 23 61 38. Fax: 33 2 23 23 61 39. E-mail: wroblews{at}univ-rennes1.fr.

{dagger} Present address: Division of Internal Medicine, Hadassah University Hospital, Ein Karem, Jerusalem, Israel.

Antimicrobial Agents and Chemotherapy, May 2002, p. 1218-1225, Vol. 46, No. 5
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.5.1218-1225.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Fassi Fehri, L., Wroblewski, H., Blanchard, A. (2007). Activities of Antimicrobial Peptides and Synergy with Enrofloxacin against Mycoplasma pulmonis. Antimicrob. Agents Chemother. 51: 468-474 [Abstract] [Full Text]  
  • Fehri, L. F., Sirand-Pugnet, P., Gourgues, G., Jan, G., Wroblewski, H., Blanchard, A. (2005). Resistance to Antimicrobial Peptides and Stress Response in Mycoplasma pulmonis. Antimicrob. Agents Chemother. 49: 4154-4165 [Abstract] [Full Text]  
  • Simmons, W. L., Denison, A. M., Dybvig, K. (2004). Resistance of Mycoplasma pulmonis to Complement Lysis Is Dependent on the Number of Vsa Tandem Repeats: Shield Hypothesis. Infect. Immun. 72: 6846-6851 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»